• Isochlorogenic Acid A Disrupts HBV Replication via HO-1

  2026-09-26

  The study finds that isochlorogenic acid A (ICAA) affects multiple stages of the hepatitis B virus life cycle, alongside HO-1 upregulation and changes in intracellular reactive oxygen species. Its results connect altered redox conditions with reduced viral products and impaired particle assembly, while leaving the causal steps to be tested more directly.

• T7 RNA Polymerase for RNA Stability Research

  2026-09-25

  T7 RNA Polymerase provides a defined way to generate RNA substrates for investigating how transcript production differs from transcript stability. This article connects in vitro transcription with recent findings on DDX21, NAT10, and ac4C-modified RNA in colorectal cancer—while clarifying what the enzyme can and cannot establish.

• Streptavidin-HyperFluor 647 Workflow Guide

  2026-09-25

  Use Streptavidin-HyperFluor 647 for sensitive far-red readout when your target carries biotin, from antibody staining to flow cytometry. For BmTyr proximity labeling, it is a complementary detection option only after adding a biotin handle; the study’s native azide-click workflow is biotin-free.

• ICAA Targets RIP3 to Reduce Cardiac Hypertrophy

  2026-09-24

  A 2026 study reports that isochlorogenic acid A (ICAA) attenuates angiotensin II- and pressure overload-induced cardiac hypertrophy by directly targeting RIP3 and suppressing downstream CaMKII signaling. Its findings distinguish this hypertrophic pathway from canonical RIP3–MLKL signaling and suggest a new mechanism for cardiovascular disease research, while leaving important questions about clinical relevance and dosing open.

• saRNA Influenza Vaccines: Dose and Durability

  2026-09-24

  A mouse study found that low-dose self-amplifying RNA vaccines generated durable antibody responses and protected against influenza B challenge where the tested conventional mRNA vaccine did not. The results point to platform- and subtype-dependent differences in dose sparing, while leaving important questions about human translation and comparative performance unresolved.

• Clasto-Lactacystin β-lactone in RIPK3 Assays

  2026-09-23

  Use Clasto-Lactacystin β-lactone to test whether proteasome activity contributes to RIPK3 loss during virus-induced necroptosis studies. This workflow pairs a fast pharmacological perturbation with genetic controls, protein-turnover readouts, and practical steps to separate pathway evidence from inhibitor toxicity.

• ALC-0159: From LNP Design to In Vivo Insight

  2026-09-23

  ALC-0159 is a PEG-conjugated lipid excipient that can support a more rigorous translational workflow for mRNA lipid nanoparticles. By pairing formulation control with PET-based measurement of encoded antigen expression, researchers can move beyond tracking delivery vehicles toward understanding where and how long biological activity occurs.

• Cardiogreen (Indocyanine Green) Workflow Guide

  2026-09-22

  Cardiogreen (Indocyanine green) bridges vascular imaging and controlled near-infrared light experiments, supporting cardiac output measurement, ophthalmic angiography, liver blood flow assessment, and photodynamic workflows. This practical guide emphasizes fresh-solution handling, optical controls, mechanistic readouts, and troubleshooting for reproducible research.

• p-Cresyl sulfate: Assays for Uremic Injury

  2026-09-22

  Build reproducible p-Cresyl sulfate exposure models that connect renal retention biology with endothelial, vascular, and biliary injury. This workflow emphasizes fresh-solution handling, albumin-aware dosing, orthogonal apoptosis measurements, and practical troubleshooting for translational assays.

• Silymarin: From Milk Thistle Extract to Translational Probe

  2026-09-21

  Silymarin is more than a familiar milk thistle extract: it is a chemically diverse flavonolignan mixture that can connect redox biology, cancer mechanisms, metabolism, and antiviral investigation. This thought-leadership guide shows how chemistry-aware design, mixture controls, and orthogonal validation can turn Silymarin into a more interpretable translational research probe.

• Dihydrotestosterone: Workflows for AR Studies

  2026-09-21

  Dihydrotestosterone enables controlled interrogation of androgen receptor signaling, EGFR–ERBB2 pathway crosstalk, and muscle-protection phenotypes in disease models. This practical guide combines dose-controlled cell assays, in vivo study design, reference-informed experimental logic, and troubleshooting for reproducible DHT research use.

• Direct Mouse Genotyping Kit: Practical PCR Guide

  2026-09-20

  The Direct Mouse Genotyping Kit supports rapid PCR amplification from mouse tissue lysates without conventional DNA purification, simplifying routine mouse genetic screening and high-throughput genotyping. It is intended for PCR-based genotyping workflows, not for recovery of highly purified genomic DNA or unvalidated downstream enzymatic applications.

• MYC2–LBD40/42 Control of Tomato Gray Mold Defense

  2026-09-19

  The reference study identifies a MYC2–LBD40/42–CRL3BPM4 module that fine-tunes tomato resistance to Botrytis cinerea by balancing defense activation with growth-related resource demands. Its central insight is that LBD40 and LBD42 act as inducible transcriptional brakes, while BPM4-mediated proteolysis releases those brakes when stronger immunity is needed.

• From Fluorescent Labels to Smarter Nanomedicine

  2026-09-18

  How 6-FAM SE can move beyond routine labeling to strengthen construct characterization, assay design, and translational decision-making in stimulus-responsive nanomedicine.

• Chlorpromazine HCl: A Smarter Endocytosis Control

  2026-09-18

  Chlorpromazine HCl is more than a dopamine receptor antagonist: it can serve as a pathway-perturbation tool in endocytosis and infection assays. This article explains how to interpret chlorpromazine experiments in Drosophila S2 cells without confusing pharmacological inhibition with definitive pathway assignment.

8568 records 1/572 page Next 12345 下5页 Last page